Back to Geriatrics
Geriatricsv2011Evidence-Based

Edmonton Symptom Assessment System-revised (ESAS-r)

Assesses symptoms of patients receiving palliative care through a standardized 9-item self-report symptom intensity tool with improved clarity and definitions.

Clinical Input Parameters

points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
points
Range: 0 — 10 points
Clinical Assessment
Awaiting Parameters
esas r total score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Edmonton Symptom Assessment System-revised (ESAS-r) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within geriatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Total ESAS-r Score = pain + tiredness + drowsiness + nausea + lack_of_appetite + shortness_of_breath + depression + anxiety + wellbeing. Each symptom is rated from 0 (none/best) to 10 (worst possible).

Clinical Pearls & Practice Notes

  • The ESAS-r is a revision of the original Edmonton Symptom Assessment System (ESAS) with improved clarity and definitions.
  • All symptoms are assessed for the current moment ('right now') rather than over a time period.
  • The revised version provides specific definitions for potentially confusing items like tiredness, drowsiness, depression, anxiety, and wellbeing.
  • Symptoms are organized with physical symptoms first (pain, tiredness, drowsiness, nausea, lack of appetite, shortness of breath) followed by psychosocial symptoms (depression, anxiety) and overall wellbeing last.
  • The tool has been validated in multiple languages and clinical settings for palliative care patients.
  • Individual symptom scores of ≥4 are often considered clinically significant and warrant intervention.
  • The tool should be used for longitudinal monitoring, with clinicians expecting to see a downward trend in scores with effective treatment.
  • Can be administered by patients themselves (self-report) or with assistance from healthcare providers.
  • Useful for symptom screening, monitoring treatment response, and communication between patients and healthcare teams.
  • The ESAS-r is widely used in palliative care, oncology, nephrology, and other specialty settings.
  • Regular reassessment is recommended to track changes in symptom burden over time.
  • The tool helps identify which specific symptoms need more targeted intervention.
  • Total scores provide an overall assessment of symptom burden, while individual scores guide specific symptom management.
  • The revised version has been shown to be easier to understand and preferred by patients compared to the original ESAS.
  • Healthcare providers have highly favorable opinions of the ESAS-r as a clinical practice tool.

Evidence & Literature Citations

  1. Watanabe S, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F. A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage. 2011;41(2):456-68. doi: 10.1016/j.jpainsymman.2010.04.020.
  2. Hui D, Bruera E. The Edmonton Symptom Assessment System 25 years later: Past, present, and future developments. J Pain Symptom Manage. 2017;53(3):630-643. doi: 10.1016/j.jpainsymman.2016.10.370.
  3. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6-9.
  4. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88(9):2164-71. doi: 10.1002/(sici)1097-0142(20000501)88:9<2164::aid-cncr24>3.0.co;2-5.

Score Interpretation Ranges

Mild0 – 17 pts

Mild total symptom burden

Moderate18 – 35 pts

Moderate total symptom burden

Severe36 – 90 pts

Severe total symptom burden

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.